Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Autor: Dalai SC; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Dines JN; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Snyder TM; Adaptive Biotechnologies, Seattle, Washington, USA., Gittelman RM; Adaptive Biotechnologies, Seattle, Washington, USA., Eerkes T; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA., Vaney P; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA., Howard S; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA., Akers K; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Skewis L; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Monteforte A; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Witte PR; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Wolf C; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Nesse H; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Herndon M; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Qadeer J; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Duffy S; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Svejnoha E; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Taromino C; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Kaplan IM; T-Detect Product Management, Adaptive Biotechnologies, Seattle, Washington, USA., Alsobrook J; Molecular Lab Management, Adaptive Biotechnologies, Seattle, Washington, USA., Manley T; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Baldo L; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Dec 19; Vol. 75 (12), pp. 2079-2087.

Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1.

Autor: Stenberg RM, Witte PR, Stinski MF

Publikováno v: Journal of virology [J Virol] 1985 Dec; Vol. 56 (3), pp. 665-75.